Literature DB >> 16714536

Interaction of neonatal phagocytes with group B streptococcus: recognition and response.

Philipp Henneke1, Reinhard Berner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16714536      PMCID： PMC1479263          DOI： 10.1128/IAI.01551-05

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


× No keyword cloud information.
  159 in total

1.  Co-operative induction of pro-inflammatory signaling by Toll-like receptors.

Authors:  A Ozinsky; K D Smith; D Hume; D M Underhill
Journal:  J Endotoxin Res       Date:  2000

2.  Role of C5a-ase in group B streptococcal resistance to opsonophagocytic killing.

Authors:  S Takahashi; Y Nagano; N Nagano; O Hayashi; F Taguchi; Y Okuwaki
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

3.  Concentrations of main serum opsonins in early infancy.

Authors:  V Drossou; F Kanakoudi; E Diamanti; V Tzimouli; T Konstantinidis; A Germenis; G Kremenopoulos; V Katsougiannopoulos
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1995-05       Impact factor: 5.747

4.  Deficient total cell content of CR3 (CD11b) in neonatal neutrophils.

Authors:  N Abughali; M Berger; M F Tosi
Journal:  Blood       Date:  1994-02-15       Impact factor: 22.113

5.  TIRAP: an adapter molecule in the Toll signaling pathway.

Authors:  T Horng; G M Barton; R Medzhitov
Journal:  Nat Immunol       Date:  2001-09       Impact factor: 25.606

6.  Tumor necrosis factor alpha acts as an autocrine second signal with gamma interferon to induce nitric oxide in group B streptococcus-treated macrophages.

Authors:  K J Goodrum; J Dierksheide; B J Yoder
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

7.  Effects of fibronectin and group B streptococci on tumour necrosis factor-alpha production by human culture-derived macrophages.

Authors:  E B Peat; N H Augustine; W K Drummond; J F Bohnsack; H R Hill
Journal:  Immunology       Date:  1995-03       Impact factor: 7.397

8.  Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity.

Authors:  M R Wessels; P Butko; M Ma; H B Warren; A L Lage; M C Carroll
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

9.  Group B streptococci elicit leukotriene B4 and interleukin-8 from human monocytes: neonates exhibit a diminished response.

Authors:  J L Rowen; C W Smith; M S Edwards
Journal:  J Infect Dis       Date:  1995-08       Impact factor: 5.226

10.  Induction of tumor necrosis factor alpha by the group- and type-specific polysaccharides from type III group B streptococci.

Authors:  G Mancuso; F Tomasello; C von Hunolstein; G Orefici; G Teti
Journal:  Infect Immun       Date:  1994-07       Impact factor: 3.441
View more
  26 in total

1.  Humanized mice, a new model to study the influence of drug treatment on neonatal sepsis.

Authors:  Wolfgang Ernst; Nicole Zimara; Frank Hanses; Daniela N Männel; Birgit Seelbach-Göbel; Anja K Wege
Journal:  Infect Immun       Date:  2013-02-25       Impact factor: 3.441

2.  Amniotic fluid neutrophils can phagocytize bacteria: A mechanism for microbial killing in the amniotic cavity.

Authors:  Nardhy Gomez-Lopez; Roberto Romero; Valeria Garcia-Flores; Yi Xu; Yaozhu Leng; Ali Alhousseini; Sonia S Hassan; Bogdan Panaitescu
Journal:  Am J Reprod Immunol       Date:  2017-07-13       Impact factor: 3.886

3.  Differing mechanisms of surviving phagosomal stress among group B Streptococcus strains of varying genotypes.

Authors:  Michelle L Korir; Clare Laut; Lisa M Rogers; Jessica A Plemmons; David M Aronoff; Shannon D Manning
Journal:  Virulence       Date:  2016-10-28       Impact factor: 5.882

4.  NO is a macrophage autonomous modifier of the cytokine response to streptococcal single-stranded RNA.

Authors:  Sachin D Deshmukh; Sabrina Müller; Katrin Hese; Katharina S Rauch; Julia Wennekamp; Osamu Takeuchi; Shizuo Akira; Douglas T Golenbock; Philipp Henneke
Journal:  J Immunol       Date:  2011-12-19       Impact factor: 5.422

5.  Group B streptococcal capsular sialic acids interact with siglecs (immunoglobulin-like lectins) on human leukocytes.

Authors:  Aaron F Carlin; Amanda L Lewis; Ajit Varki; Victor Nizet
Journal:  J Bacteriol       Date:  2006-09-22       Impact factor: 3.490

6.  Insulin modulates the inflammatory granulocyte response to streptococci via phosphatidylinositol 3-kinase.

Authors:  Sybille Kenzel; Miriam Mergen; Julius von Süßkind-Schwendi; Julia Wennekamp; Sachin D Deshmukh; Monika Haeffner; Antigoni Triantafyllopoulou; Sebastian Fuchs; Susan Farmand; Sandra Santos-Sierra; Jochen Seufert; Timo K van den Berg; Taco W Kuijpers; Philipp Henneke
Journal:  J Immunol       Date:  2012-09-26       Impact factor: 5.422

Review 7.  Potential of immunomodulatory agents for prevention and treatment of neonatal sepsis.

Authors:  J L Wynn; J Neu; L L Moldawer; O Levy
Journal:  J Perinatol       Date:  2008-09-04       Impact factor: 2.521

8.  The two-component response regulator LiaR regulates cell wall stress responses, pili expression and virulence in group B Streptococcus.

Authors:  David C Klinzing; Nadeeza Ishmael; Julie C Dunning Hotopp; Hervé Tettelin; Kelly R Shields; Lawrence C Madoff; Karen M Puopolo
Journal:  Microbiology       Date:  2013-05-23       Impact factor: 2.777

9.  Extracellular nucleotide catabolism by the Group B Streptococcus ectonucleotidase NudP increases bacterial survival in blood.

Authors:  Arnaud Firon; Marcia Dinis; Bertrand Raynal; Claire Poyart; Patrick Trieu-Cuot; Pierre Alexandre Kaminski
Journal:  J Biol Chem       Date:  2014-01-15       Impact factor: 5.157

10.  Role of Toll-like receptor 2 in innate resistance to Group B Streptococcus.

Authors:  Iain R Asplin; David J Carl; Sing Sing Way; Amanda L Jones
Journal:  Microb Pathog       Date:  2007-08-10       Impact factor: 3.738
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.